Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
First Wave Biopharma Inc
(NQ:
FWBI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about First Wave Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
First Wave BioPharma’s Fast-Tracked Phase 2 Candidate To Treat COVID-RELATED GI Tract Infection Gives Hope To Millions (NASDAQ: FWBI)
March 02, 2022
Via
AB Newswire
First Wave BioPharma On Track For Transformational 2022, EUA And Phase-2 COVID-Related GI Trial Data In Focus (NASDAQ: FWBI)
February 17, 2022
Via
AB Newswire
First Wave BioPharma Files Two Provisional US Patent Applications For Adrulipase
January 13, 2022
First Wave BioPharma Inc (NASDAQ: FWBI) has filed two new provisional patent applications on adrulipase with the U.S. Patent and Trademark Office (USPTO). ...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...
Via
Benzinga
With Full Enrollment Complete In Its Phase 2 COVID-Related GI Treatment Trial, First Wave Bio Could Earn An EUA Sooner Than Later (NASDAQ: FWBI)
January 11, 2022
Via
AB Newswire
EXCLUSIVE: First Wave BioPharma CEO Talks COVID-19 Trial, Says 'If The Data Is Positive, I Think The Sky Is The Limit For Our Stock'
January 06, 2022
First Wave BioPharma Inc (NASDAQ: FWBI) announced Thursday it completed enrollment for Part 2 of the RESERVOIR Phase 2 trial evaluating FW-COV, the company's...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 03, 2022
Gainers Indaptus Therapeutics (NASDAQ:INDP
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 15, 2021
Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 14, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX) stock increased by 134.05% to $3.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 10, 2021
Gainers Quoin Pharmaceuticals (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 10, 2021
Gainers Reshape Lifesciences (NASDAQ:RSLS...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 09, 2021
Gainers Applied DNA Sciences (NASDAQ:APDN...
Via
Benzinga
First Wave BioPharma Stock Jumps On Niclosamide's Favorable Safety Profile In COVID-19 Related GI Infections
November 30, 2021
The independent data monitoring committee (DMC) has recommended First Wave BioPharma Inc (NASDAQ: FWBI) to continue enrollment in Part 2 of the RESERVOIR Phase 2...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
Upgrades For CarMax Inc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 30, 2021
Gainers Cumberland (NASDAQ:CPIX) shares rose 91.81% to $4.22 during Tuesday's pre-market session. The company's market cap stands at $62.4 million. First Wave...
Via
Benzinga
First Wave Restructures Merger Consideration Payment Terms
November 16, 2021
First Wave BioPharma Inc (NASDAQ: FWBI) has agreed with the former shareholders of First Wave Bio Inc to amend the payment structure of the initial...
Via
Benzinga
64 Biggest Movers From Yesterday
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
40 Stocks Moving In Monday's Mid-Day Session
November 01, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the...
Via
Benzinga
48 Biggest Movers From Yesterday
October 21, 2021
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO...
Via
Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
October 20, 2021
Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (...
Via
Benzinga
Exposures
Product Safety
Mid-Morning Market Update: Markets Open Higher; Verizon Posts Upbeat Earnings
October 20, 2021
Following the market opening Wednesday, the Dow traded up 0.35% to 35,580.21 while the NASDAQ rose 0.11% to 15,146.02. The S&P also rose, gaining 0.32% to 4,533.97. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
A Deeper Dive Into AzurRx BioPharma’s Acquisition Of First Wave Bio; Low Up-Front Terms Are Very Shareholder Friendly (NASDAQ: FWBI)
October 20, 2021
Via
AB Newswire
First Wave BioPharma Initiates Phase2b Trial Targeting Unmet Treatment For Ulcerative Proctitis And UPS; Adds To Growing List Of 2021 Milestones (NASDAQ: FWBI)
October 18, 2021
Via
AB Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 07, 2021
Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 20.46% to $0.8 during Thursday's pre-market session. The company's market cap stands at $68.5 million...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.